Biosimilars and Biologics: Implementation and Monitoring in A Healthcare Setting

Get Up to Speed on the Fastest Growing Pharmaceutical Innovation With the Only Guide Written for Pharmacists_x000d_
Among the most anticipated and discussed segments of the pharmaceutical market, biosimilars, are finally beginning to exert a greater impact on practice._x000d_
To meet the growing need for information, ASHP has published Biosimilars and Biologics. This authoritative, evidence-based resource provides an in-depth perspective on all areas related to these innovative drugs, including:_x000d_
Legislative/regulatory issues, including the biosimilars act and anticipated FDA guidelines_x000d_
The safety, efficacy, and interchangeability of biologics_x000d_
The science and analytical chemistry associated with the manufacture of biologics_x000d_
Needed pharmacovigilance and adverse effect reporting systems_x000d_
Formulary management